The economy of the country and the world is struggling with a crisis due to the second powerful wave of coronavirus. The number of new cases in unlocking is increasing daily in India too. In such a situation, efforts to bring the Covid-19 vaccine as soon as possible have received a major blow.
AstraZeneca has stopped the trial of the vaccine Kovyshield made at Oxford University in the US because of a volunteer sick. At the same time, 9 pharmaceutical companies in the US have promised that they will not launch the premature vaccine market.
Trials of the Oxford Vaccine Stopped
The phase-3 trials of Vaccine Coveshield of Oxford University and AstraZeneca, currently leading the vaccine race, have been temporarily halted. A volunteer has become ill. It is not understood whether this is a side effect of the vaccine shot or something. AstraZeneca has begun its investigation.
The company stated on Tuesday evening, saying that the standard review process has been stopped so that the safety data can be reviewed. AstraZeneca has not mentioned anything about the possible side effects. It is only said that it is 'Potentially unexplained illness'.
Health news site STAT was the first to report this news. A spokesperson for AstraZeneca has confirmed that it is in Volunteer UK. After this, AstraZeneca has stopped Phase-3 trials all over the world including America, India.
In the past month itself, AstraZeneca has started tests on 30,000 people in the US. Apart from this, trials of this Oxford University vaccine have started in Britain, Brazil, South Africa as well as India. Serum Institute of India is conducting its trials in India.
Kovaxin will be available next year
India's first indigenous Covid-19 vaccine Kovaxin will be launched early next year. It has been developed by Bharat Biotech in association with ICMR. Kovaxin has started Phase-1 trials. The central government has approved phase-2 trials from 7 September.
Sanjay Rai, a community medicine professor at AIIMS and principal investigator of the Covid-19 vaccine, said the Phase-1 trials were successful. Phase-2 trials will be completed in October. Phase-3 trials will begin after this. This means that covaxin will be available by early 2021.
Efforts on phase-3 testing of Russian vaccine in India intensify
Russia has approached India for phase-3 trials of its Covid-19 vaccine Sputnik V and its production. NITI Aayog member Dr VK Paul said that the government understands the great importance of this offer of partnership with very special friends. There have been significant efforts on this.
Member (Health) in NITI Aayog, Dr. Paul also said that Russia had approached several companies of the country for the production of vaccines. Four companies have also come forward for this. The government is trying to see how these companies can connect with Russian authorities.
9 pharmaceutical companies promised vaccine will be safe
Nine pharmaceutical companies have issued a joint pledge, dismissing pressure to bring the Covid-19 vaccine before the US presidential elections. He has said in this that the safety of people who will be vaccinated will be at the top.
The CEOs of AstraZeneca, BioNotech, GlaxoSmithKline (GSK), Johnson & Johnson, Merck (MSD), Moderna, Novavax, Pfizer, and Sanofi have signed on to the pledge. The initiative comes at a time when US President Donald Trump is trying to get treatment and vaccine approved as soon as possible to fight the epidemic.
Trump also hinted on Monday that the US may approve the Covid-19 vaccine ahead of the presidential elections on November 3, or in October. It is clear from the pledge of nine pharmaceutical companies that none of these companies will ask for premature approval before the trial ends.
The water crisis in Delhi: 'Two tankers are needed, only one is being sent and that too half', Delhi government's meeting on water shortage
These days, North India is facing the brunt of intense heat. In many areas, the mercury has reached close to 50. The heat is also being seen in the capital Delhi. Meanwhile, Delhiites are also facing
NATA Admit Card 2022: Admit card issued for National Aptitude Test in Architecture, here's how to download
NATA Admit Card 2022: The Council of Architecture (COA) has released the admit card for the National Aptitude Test in Architecture NATA. Students will get this admit card through online mode.
Devara Trailer: Censorship on questions, rude security personnel, influencers in the front seats at the trailer launch of Devara
These days, a special style is seen everywhere in the trailer release programs of films in Mumbai and that is to call film journalists, editors, etc., and not give them a chance to ask questions. At
In 24 hours, there were 82,214 infections and 77,488 people recovered; Six days later the number of patients increased again; More than 58 lakh cases in the country
There have been 82,214 cases of infection in 24 hours in the country, while 77,488 people have been cured. After six days the number of infectives increased from the recovered patients. With this, 58
Defense Minister said: India has never been a supporter of war and violence, it is not our nature to remain neutral on injustice
India neither harms others nor spares troublemakers. India has never been in favor of war and violence. However, it cannot remain neutral towards injustice and oppression. It is not in our nature to
New Education Policy HPU: The semester system will be implemented again in the UG degree course in Himachal, instructions issued after meeting
Himachal Pradesh University is going to implement National Education Policy-2020 in undergraduate degree courses in UG degree courses from the academic session 2022-23 itself. Under the new education
Survey of madrasas completed in UP: About eight thousand unrecognized were found, Moradabad has the highest
The ongoing survey regarding madrassas in Uttar Pradesh has been completed. About eight thousand madrasas have been found unrecognized in the entire state. However, in this regard by November 15, all
Announcement of new vaccination policy: States will now get 75% of the vaccine from the center instead of 50%, but if the wastage is high, the supply will be affected.
Prime Minister Narendra Modi announced on Monday that from June 21, those above the age of 18 will also get the benefit of the free vaccine. A day after the Prime Minister's announcement, that is, on
Kejriwal ready to change scheme after Center objects to doorstep delivery of ration, said - we don't need credit
Chief Minister Arvind Kejriwal on Saturday said how the 'Mukhyamantri Gantri Ghar Ghar Ration Yojana', which has been brought for doorstep delivery of rations in Delhi, can be started despite the
'A big attack is going to happen, don't travel in Air India', threat from Khalistani terrorist Gurpatwant Singh Pannun.
Khalistani terrorist Gurpatwant Singh Pannu on Monday threatened passengers not to travel on Air India flights from November 1 to 19. According to a report by India Today, he claimed that an Air India
